# Eli Lilly and Company (India) has issued a high alert warning to patients and healthcare providers following a major crackdown on counterfeit medicines in Haryana.

*biotech · news · 2026-04-30 · The Tribune*

## Key points

- Counterfeit Mounjaro (tirzepatide) injections worth Rs 56 lakh were seized in Gurugram, Haryana.
- The seized fake Mounjaro products were not made by Eli Lilly and did not enter the approved supply chain.
- Eli Lilly's tirzepatide is officially sold in India only as Mounjaro and Yurpeak brands.
- Lilly emphasizes purchasing only through authorized distributors and pharmacies to avoid counterfeit medications.
- The company confirmed that genuine supply channels for Mounjaro remain unaffected by the seizures.

**Companies:** Eli Lilly and Company
**Countries:** India

[Read the full story on The Tribune](https://www.tribuneindia.com/news/delhi/eli-lilly-issues-high-alert-after-rs-56-lakh-fake-mounjaro-injections-seized-in-gurugram/)

---

Canonical: https://newsio.io/n/6d9ebf91-56a1-406c-8580-e1231be5d182/eli-lilly-and-company-india-has-issued-a-high-alert-warning-to-patients-and-heal
Summarized by Newsio from The Tribune. https://newsio.io/how-it-works